Genta, Inc (fka GNTAQ)

[StoxTrax]

Genta is "Poised to Pop" Article just out 5/12

http://newsblaze.com/story/20100512120419trho.nb/topstory.html

Great news for us longs! Can't wait for tomorrow!

Here is the full article:

Genta is 'Poised to Pop' (GETA.OB)

By Traci Hogg

Genta Incorporated (GETA.OB) is a biopharmaceutical company focused on the identification, development and commercialization of drugs for the treatment of people with cancer.

Genta has three promising drugs in their pipeline: Tesetaxel, Genasense® and Oral Gallium. Tesetaxel, a novel oral targeted tubulin inhibitor, was just granted Fast Track Designation by the FDA for Advanced Gastric Cancer. They also have a product in the market called Ganite® (gallium nitrate injection), which is an important therapy used for serious cancer complications.

Genta has scheduled a conference call for May 13th before market open to discuss First Quarter 2010 Highlights. They will also be presenting at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting being held from June 4-9, 2010 in Chicago, IL.

Currently Genta's stock price has bottomed at around .06 (which is a far cry from its 52 week high of $1.26.) According to Market Financial, Genta is "Poised For A Rebound Year Based On Latest Company Developments." Genta's stock will be volatile this week and could easily triple on good news from the Company. Genta is current, and always has been, with all SEC filings.